Vapogenix

Vapogenix is a clinical-stage company dedicated to developing novel non-narcotic analgesics for localized pain.Vapogenix's products are formulated with volatile anesthetics, which, in their unformulated state, are currently only used as inhaled general anesthetics.Vapogenix's first product recently completed its first clinical trial; it is a fast-acting and effective local analgesic that alleviates pain associated with venipuncture, intravenous cannulation, and minor dermatological procedures. The company’s next product will focus on treating wound pain and localized inflammatory pain.